September 2025
1. TILLMANN HL
   Finite Treatments for Viral Hepatitis: Is "Sustained Control" Versus Cure Acceptable for HBV?
   Am J Gastroenterol. 2025 Sep 19. doi: 10.14309/ajg.0000000000003719.
   

   >> Share

   
   August 2025
2. CHAUDHARY U, Anouti A, Rule JA, Lee WM, et al
   Evolution of Hepatitis A-Related Acute Liver Failure in North America Over 22 Years.
   Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003743.
   

   >> Share

   
   July 2025
3. MAGERAS A, Rodriguez N, Katzenstein C, Lee F, et al
   Novel Implementation of Hepatitis B to Hepatitis Delta Reflex Testing in a United States Healthcare System.
   Am J Gastroenterol. 2025 Jul 31. doi: 10.14309/ajg.0000000000003688.
   

   >> Share

   
   
4. CHEN YC, Jeng WJ, Chien RN, Liaw YF, et al
   Switching to entecavir >3 months before the end of tenofovir-based therapy in HBeAg-negative patients may reduce early relapse and hepatitis flare.
   Am J Gastroenterol. 2025 Jul 2. doi: 10.14309/ajg.0000000000003630.
   

   >> Share

   
   June 2025
5. YANG Z, Kupferman J, Zhang W, Singal AK, et al
   Short- and Long-Term Outcomes among a National Cohort of U.S. Veterans Hospitalized for Alcohol-Associated Hepatitis.
   Am J Gastroenterol. 2025 Jun 9. doi: 10.14309/ajg.0000000000003581.
   

   >> Share

   
   April 2025
6. SINGAL AK, Piano S
   Tapered Corticosteroids in Severe Alcohol-Associated Hepatitis: A Strategy to Maximize Benefit and Minimize Harm.
   Am J Gastroenterol. 2025 Apr 28. doi: 10.14309/ajg.0000000000003464.
   

   >> Share

   
   
7. MOON AM, Lupu GV, Green EW, Deutsch-Link S, et al
   Rural-urban disparities in hepatocellular carcinoma deaths are driven by hepatitis C-related HCC.
   Am J Gastroenterol. 2025 Apr 11. doi: 10.14309/ajg.0000000000003487.
   

   >> Share

   
   March 2025
8. KULKARNI AV, Kumar K, Giri S, Arab JP, et al
   Infections in Standard or Tapered Dose of Prednisolone for Alcohol-Associated Hepatitis: A Randomized Trial (STASH Trial).
   Am J Gastroenterol. 2025 Mar 13. doi: 10.14309/ajg.0000000000003416.
   

   >> Share

   
   December 2024
9. CHUNG SW, Kim YJ, Lim J, Choi J, et al
   Risk of extrahepatic malignancies in patients with autoimmune hepatitis: a nationwide cohort study.
   Am J Gastroenterol. 2024 Dec 24. doi: 10.14309/ajg.0000000000003261.
   

   >> Share

   
   
10. WU Y, Zhang Z
    Comments on Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACTB Study).
    Am J Gastroenterol. 2024 Dec 16. doi: 10.14309/ajg.0000000000003206.
    

    >> Share

    
    
11. TERRAULT NA, Vargas HE
    Antivirals in Preventing Perinatal Transmission of Hepatitis B: Start and Stop Times are Shifting.
    Am J Gastroenterol. 2024 Dec 10. doi: 10.14309/ajg.0000000000003177.
    

    >> Share

    
    November 2024
12. LV J
    Challenges in Expanding Structured Chronic Hepatitis B Surveillance Programs.
    Am J Gastroenterol. 2024 Nov 20. doi: 10.14309/ajg.0000000000003187.
    

    >> Share

    
    October 2024
13. COLAPIETRO F, Piovani D, Pugliese N, Aghemo A, et al
    Is ChatGPT a reliable tool in Autoimmune Hepatitis?
    Am J Gastroenterol. 2024 Oct 31. doi: 10.14309/ajg.0000000000003179.
    

    >> Share

    
    
14. WENTWORTH BJ, McGrath M, Khanna S, Lammert C, et al
    Autoimmune Hepatitis and the Pathways and Targets for Therapies.
    Am J Gastroenterol. 2024 Oct 25. doi: 10.14309/ajg.0000000000003163.
    

    >> Share

    
    
15. ZENG QL, Zhou YH, Dong XP, Zhang JY, et al
    Expected Eight-Week Prenatal Versus Twelve-Week Perinatal Tenofovir Alafenamide Prophylaxis to Prevent Mother-To-Child Transmission of Hepatitis B Virus: A Multicenter, Prospective, Open-label, Randomized Controlled Trial.
    Am J Gastroenterol. 2024 Oct 9. doi: 10.14309/ajg.0000000000003122.
    

    >> Share

    
    
16. CHAI KP, Saxena V, Seo S, Horton BH, et al
    A chronic hepatitis B identification and surveillance program improves care in an integrated health plan.
    Am J Gastroenterol. 2024 Oct 4. doi: 10.14309/ajg.0000000000003116.
    

    >> Share

    
    August 2024
17. MISHRA AK, Shasthry SM, Vijayaraghavan R, Kumar G, et al
    Granulocyte colony stimulating factor improves Prednisolone responsiveness and 90-day survival in steroid eligible severe Alcohol associated Hepatitis: The GPreAH Study a randomized trial.
    Am J Gastroenterol. 2024 Aug 20. doi: 10.14309/ajg.0000000000003038.
    

    >> Share

    
    July 2024
18. DUKEWICH M, Dodge JL, Lucey MR, Rice JP, et al
    The Survival Benefit of Re-abstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multi-Center ACCELERATE Study.
    Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002956.
    

    >> Share

    
    
19. LEE WM, Barnard C, Rule JA, Orandi BJ, et al
    Association of Acetaminophen (Paracetamol) Use with Severity and Outcomes in Patients with Viral Hepatitis-Associated Acute Liver Failure.
    Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002941.
    

    >> Share

    
    June 2024
20. HUANG SC, Su TH, Tseng TC, Liao SH, et al
    Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B.
    Am J Gastroenterol. 2024 Jun 26. doi: 10.14309/ajg.0000000000002915.
    

    >> Share

    
    May 2024
21. RAO S, Qazi S, Lee D, Molliner C, et al
    Multiple Barriers Impede Screening for Hepatitis Delta: An Internet-Based Survey of Healthcare Providers.
    Am J Gastroenterol. 2024 May 9. doi: 10.14309/ajg.0000000000002810.
    

    >> Share

    
    
22. KARIME C, Black CN, Cortes P, Kwon JY, et al
    Utility of a Third Heplisav-B Dose in Patients with Inflammatory Bowel Disease without Immunity Following Two-Dose Heplisav-B Vaccination.
    Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002863.
    

    >> Share

    
    April 2024
23. HUME SJ, Holmes JA, Thompson AJ
    Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of Hepatic Decompensation?
    Am J Gastroenterol. 2024 Apr 15. doi: 10.14309/ajg.0000000000002766.
    

    >> Share

    
    
24. WANG Y, Huang Y, Antwi SO, Taner CB, et al
    Racial Disparities in Liver Disease Mortality Trends Among Black and White Populations in the United States, 1999-2020: An Analysis of CDC WONDER Database.
    Am J Gastroenterol. 2024;119:682-689.
    

    >> Share

    
    March 2024
25. HIRODE G, Hansen BE, Chen CH, Su TH, et al
    Limited sustained remission after nucleos(t)ide analogue withdrawal: Results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study).
    Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002759.
    

    >> Share

    
    
26. HIRODE G, Hansen BE, Chen CH, Su TH, et al
    Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
    Am J Gastroenterol. 2024 Mar 8. doi: 10.14309/ajg.0000000000002718.
    

    >> Share

    
    February 2024
27. BUI H, Kumar NG, Singal AG, Boparai J, et al
    Implementation of a hepatocellular carcinoma surveillance program in a community-based integrated health system in patients with hepatitis C cirrhosis.
    Am J Gastroenterol. 2024 Feb 9. doi: 10.14309/ajg.0000000000002704.
    

    >> Share

    
    
28. HSU CE, Liaw YF
    Hepatitis B Surface Antigen Kinetics After Tenofovir Withdrawal in Chronic Hepatitis B.
    Am J Gastroenterol. 2024;119:389-390.
    

    >> Share

    
    January 2024
29. JOPHLIN LL, Singal AK, Bataller R, Wong RJ, et al
    ACG Clinical Guideline: Alcohol-Associated Liver Disease.
    Am J Gastroenterol. 2024;119:30-54.
    

    >> Share

    
    December 2023
30. HU TH, Luh DL, Tsao YY, Lin TY, et al
    Utilizing the Diabetes Care System for A County-wide Hepatitis C Elimination: An Integrated Community-based Shared Care Model in Taiwan.
    Am J Gastroenterol. 2023 Dec 12. doi: 10.14309/ajg.0000000000002624.
    

    >> Share

    
    
31. BARRITT AS 4TH, Barnhart H, Gu J, Dellinger A, et al
    When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.
    Am J Gastroenterol. 2023;118:2301-2304.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share